+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease



Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease



Current Opinion in Pulmonary Medicine 24(3): 309-317



The process of aging involves biological changes that increases susceptibility for disease. In the aging lung disease IPF, GWAS studies identified genes associated with risk for disease. Recently, several of these genes were also found to be involved in risk for COPD or lung cancer. This review describes GWAS-derived risk genes for IPF that overlap with risk genes for lung cancer or COPD. Risk genes that overlap between aging lung diseases, include FAM13A, DSP and TERT. Most interestingly, disease predisposing alleles for IPF are opposite to those for COPD or lung cancer. Studies show that the alleles are associated with differential gene expression and with physiological traits in the general population. The opposite allelic effect sizes suggest the presence of trade-offs in the aging lung. For TERT, the trade-off involves cellular senescence versus proliferation and repair. For FAM13A and DSP, trade-offs may involve protection from noxious gases or tissue integrity. The overlap in risk genes in aging lung diseases provides evidence that processes associated with FAM13A, DSP and TERT are important for healthy aging. The opposite effect size of the disease risk alleles may represent trade-offs, for which a model involving an apicobasal gene expression gradient is presented.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065632006

Download citation: RISBibTeXText

PMID: 29517586

DOI: 10.1097/mcp.0000000000000476


Related references

Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 186(4): 306-313, 2012

Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prevention Research 5(3): 365-373, 2012

Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need. JAMA 313(9): 936-948, 2015

OA04.06 Examining Pleiotropic Associations of Genetic Risk Variants for Chronic Obstructive Pulmonary Disease with Lung Cancer Risk. Journal of Thoracic Oncology 12(1): S257-S258, 2017

Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 33(1): 55-60, 2010

Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis. Current Opinion in Pulmonary Medicine 20(5): 414-420, 2015

Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Journal of Proteomics 189: 23-33, 2018

Contribution of multiple inert gas elimination technique to pulmonary medicine. 2. Chronic pulmonary diseases: chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Thorax 49(9): 924-932, 1994

Chronic bronchopneumonia with diffuse interstitial pulmonary fibrosis (with special reference to the differential diagnosis of pulmonary tuberculosis, lung cancer, pulmonary fibrosis, and purulent lung disease. Iryo 16: 323-336, 1962

Influence of Pulmonary Rehabilitation on Lung Function Changes After the Lung Resection for Primary Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. Aging and Disease 6(6): 466-477, 2015

Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 21(1): 35-42, 2004

Cellular senescence and senescence-associated secretory phenotype: comparison of idiopathic pulmonary fibrosis, connective tissue disease-associated interstitial lung disease, and chronic obstructive pulmonary disease. Journal of Thoracic Disease 11(3): 857-864, 2019

The Impact of Combined Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease on Long-term Survival After Lung Cancer Surgery. Haigan 53(1): 7-11, 2013

The impact of combined pulmonary fibrosis and chronic obstructive pulmonary disease on long-term survival after lung cancer surgery. Thoracic and Cardiovascular Surgeon 62(4): 332-337, 2015

Efficacy and safety of moguisteine in comparison with levodropropizine in patients with cough associated with chronic obstructive pulmonary disease, lung cancer, or pulmonary fibrosis. Current Therapeutic Research. 55(3): 251-261, 1994